These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16861316

  • 1. Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases.
    Linton KM, Taylor MB, Radford JA.
    Br J Radiol; 2006 Aug; 79(944):e40-4. PubMed ID: 16861316
    [Abstract] [Full Text] [Related]

  • 2. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla JF, Sainz-Esteban A, Barragán J, Portilla-Quattrociocchi H, Carril JM.
    Rev Esp Med Nucl; 2008 Aug; 27(3):168-75. PubMed ID: 18570858
    [Abstract] [Full Text] [Related]

  • 3. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib.
    Kim HC, Lee JM, Choi SH, Han H, Kim SS, Lee SH, Han JK, Choi BI.
    Korean J Radiol; 2004 Aug; 5(3):157-63. PubMed ID: 15467412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
    Vanel D, Albiter M, Shapeero L, Le Cesne A, Bonvalot S, Le Pechoux C, Terrier P, Petrow P, Caillet H, Dromain C.
    Eur J Radiol; 2005 Apr; 54(1):118-23. PubMed ID: 15797301
    [Abstract] [Full Text] [Related]

  • 7. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W.
    Neoplasma; 2003 Apr; 50(6):438-42. PubMed ID: 14689066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
    Goldstein D, Tan BS, Rossleigh M, Haindl W, Walker B, Dixon J.
    Oncology; 2005 Apr; 69(4):326-32. PubMed ID: 16293972
    [Abstract] [Full Text] [Related]

  • 10. [A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].
    Murakami M, Ebisui C, Okada K, Okamura S, Murata K, Nakagomi N, Tamai M, Kinuta M.
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):99-101. PubMed ID: 24423961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
    Schindler CG, Armbrust T, Gunawan B, Langer C, Füzesi L, Ramadori G.
    Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A resected case of postoperative liver metastasis of a gastrointestinal stromal tumor showing complete response after imatinib treatment].
    Yamamura M, Hirai T, Higashida M, Kubota H, Murakami H, Kawabe Y, Ikeda M, Hirabayashi Y, Okawaki M, Hironaka K, Oka Y, Okumura H, Akiyama T, Matsumoto H, Urakami A, Yamashita K, Yamaguchi Y, Tsunoda T.
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1945-9. PubMed ID: 19011349
    [Abstract] [Full Text] [Related]

  • 19. Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.
    Ryu MH, Lee JL, Chang HM, Kim TW, Kang HJ, Sohn HJ, Lee JS, Kang YK.
    Jpn J Clin Oncol; 2006 Jan; 36(1):17-24. PubMed ID: 16418188
    [Abstract] [Full Text] [Related]

  • 20. Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene.
    Yamaguchi M, Matsumoto T, Tate G, Higuchi T.
    J Gastroenterol; 2004 Sep; 39(9):904-5. PubMed ID: 15565413
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.